VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,742 | +79.4% | 54,394 | +110.0% | 0.00% | – |
| Q2 2023 | $415,695 | -93.2% | 25,900 | -96.7% | 0.00% | -100.0% |
| Q1 2023 | $6,080,674 | -84.2% | 783,592 | -60.7% | 0.00% | -88.9% |
| Q4 2022 | $38,535,003 | -9.2% | 1,991,473 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $42,438,000 | +46.9% | 1,991,473 | -6.2% | 0.01% | +42.9% |
| Q2 2022 | $28,892,000 | -41.1% | 2,122,851 | +1.6% | 0.01% | -30.0% |
| Q1 2022 | $49,083,000 | +6.0% | 2,089,520 | +20.6% | 0.01% | +11.1% |
| Q4 2021 | $46,311,000 | +59.2% | 1,733,182 | +0.3% | 0.01% | +50.0% |
| Q3 2021 | $29,090,000 | +31.2% | 1,728,348 | -0.6% | 0.01% | +20.0% |
| Q2 2021 | $22,170,000 | – | 1,738,693 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |